The clinical significance of epidermal growth factor receptor (egf-r) in human breast cancer: A review on 5232 patients

Endocrine Reviews

Volumn 13, Issue 1, 1992, Pages 316-328

  Klijn, J G M ^a   Berns, P M J J ^a   Foekens, J A ^a   Schmitz, P I M ^b  

^a Department of Medical Oncology ^*  (Netherlands)

^b Department of Obstetrics and Gynecology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; MITOXANTRONE; PLASMINOGEN ACTIVATOR; STEROID RECEPTOR; TAMOXIFEN;

AGE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL GROWTH; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MENOPAUSE; ONCOGENE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR DIFFERENTIATION; TUMOR VOLUME;

BREAST NEOPLASMS; HUMAN; ONCOGENES; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; RECEPTORS, STEROID; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0026571910     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/edrv-13-1-3     Document Type: Article

References (102)

1. Carpenter G, Cohen S 1979 Epidermal growth factor. Annu Rev Biochem 48:193
2. Carpenter G 1981 Epidermal growth factor. Handb Exp Pharmacol 57:90
3. Stoschek CM, King LE 1986 Role of epidermal growth factor in carcinogenesis. Cancer Res 46:1030
4. Fisher DA, Lakshmanan J 1990 Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 11:418
5. Dickson RB, Lippman ME 1988 Control of human breast cancer by estogen, growth factors, and oncogenes. In: Lippman ME, Dickson RB (eds) Breast Cancer: Cellular and Molecular Biology. Kluwer Press, Boston, p 119
6. Dickson RB 1990 Stimulatory and inhibitory growth factors and breast cancer. J Steroid Biochem Mol Biol 37:795
7. Downward J, Parker P, Waterfield MD 1984 Autophosphorylation sites on the epidermal growth factor receptor. Nature 311:483
8. Neal DE, Bennett MK, Hall RR, Marsh C, Abel PD, Sainsbury JRC, Harris AL 1985 Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet 1:366
9. Yasui W, Hata J, Yokozaki H, Nakatani H, Ochiai A, Ito H, Tahara E 1988 Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer 41:211
10. Dazzi H, Hasleton PS, Thatcher N, Barnes DM, Wilkes S, Swindell R, Lawson RA 1989 Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival. Br J Cancer 59:746
11. Osborne CK, Hamilton B, Titus G, Livingston RB 1980 Epidermal growth factor stimulation on human breast cancer cells in culture. Cancer Res 40:2361
12. Fitzpatrick SL, LaChance MP, Schultz GS 1984 Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res 44:3342
13. Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS 1984 Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res 44:3448
14. McGuire WL 1991 Breast cancer prognostic factors. Editorial. J Natl Cancer Inst 83:154
15. Peyrat JP, Bonneterre J, VandeWalle B, Djiane J, Lefebvre J 1984 EGF receptors in human breast cancers; relations with hormone receptors. Ann Endocrinol (Paris) 45:412
16. Perez R, Pascual M, Macias A, Lage A 1984 Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat 4:189
17. Skoog L, Macias A, Azavedo E, Lombardero J, Klintenberg C 1986 Receptors for EGF and oestradiol and thymidinekinase activity in different histological subgroups of human mammary carcinomas. Br J Cancer 54:271
18. Macias A, Azavedo E, Perez R, Rutquist LE, Skoog L 1986 Receptors for epidermal growth factor in human mammary carcinomas and their metastases. Anticancer Res 6:849
19. Macias A, Azavedo E, Hagerstrom T, Klintenberg C, Perez R, Skoog L 1987 Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. Anticancer Res 7:459
20. Rios MA, Macias A, Perez R, Lage A, Skoog L 1988 Receptors for epidermal growth factor and estrogen as predictors of relapse in patients with mammary carcinoma. Anticancer Res 8:173
21. Sainsbury JRC, Sherbet GV, Farndon JR, Harris AL 1985 Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet 1:364
22. Sainsbury JRC, Malcolm AJ, Appleton DR, Farndon JR, Harris AL 1985 Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38:1225
23. Sainsbury JRC, Needham GK, Farndon JR, Malcolm AJ, Harris AL 1987 Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1:1398
24. Harris AL, Nicholson S 1988 Epidermal growth factor receptors in human breast cancer. In: Lippmann ME, Dickson RB (eds) Breast Cancer: Cellular and Molecular Biology. Kluwer Academic Publishers, Boston, p 93
25. Nicholson S, Sainsbury JRC, Needham GK, Chambers P, Farndon JR, Harris AL 1988 Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer 42:36
26. Sainsbury JRC, Nicholson S, Angus B, Farndon JR, Malcolm AJ, Harris AL 1988 Epidermal growth factor receptor status of histological sub-types of breast cancer. Br J Cancer 58:458
27. Nicholson S, Sainsbury JRC, Halcrow P, Chambers P, Farndon JR, Harris AL 1989 Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet 1:182
28. Harris AL 1990 Epidermal growth factor receptor: a marker of early relapse in breast cancer: interactions with neu. Eur J Cancer 26:154 (Abstract 29)
29. Nicholson S, Wright C, Sainsbury JRC, Halcrow P, Kelly P, Angus B, Farndon JR, Harris AL 1990 Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. J Steroid Biochem Mol Biol 37:811
30. Wyss R, Fabro D, Regazzi R, Borner C, Takahashi A, Eppenberger U 1987 Phorbol ester and epidermal growth factor receptors in human breast cancer. Anticancer Res 7:721
31. Costa S, Stamm H, Almendral A, Ludwig H, Wyss R, Fabbro D, Ernst A, Takahashi A, Eppenberger U 1988 Predictive value of EGF receptor in breast cancer. Lancet 2:1258
32. Pekonen F, Partanen S, Makinen T, Rutanen E-M 1988 Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 48:1343
33. Delarue JC, Friedman S, Mouriesse H, May-Levin F, Sancho-Garnier H, Contesso G 1988 Epidermal growth factor receptor in human breast cancers: correlation with estrogen and progesterone receptor. Breast Cancer Res Treat 11:173
34. Spyratos F, Delarue J-C, Andrieu C, Lidereau R, Champeme MH, Hacene K, Brunet M 1990 Epidermal growth factor receptors and prognosis in primary breast cancer. Breast Cancer Res Treat 17:83
35. Battaglia F, Polizzi G, Scambia G, Rossi S, Panici PB, Iacobelli S, Crucitti F, Mancuso S 1988 Receptors for epidermal growth factor and steroid hormones in human breast cancer. Oncology 45:424
36. Battaglia F, Scambia G, Rossi S, Panici PB, Bellantrone R, Polizzi G, Querzoli P, Negrini R, Iacobelli S, Crucitti F, Mancuso S 1988 Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol 24:1685
37. Cappelletti V, Brivio M, Miodini P, Granata G, Coradini B, Di Fronzo G 1988 Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors. Tumor Biol 9:200
38. Grimaux M, Romain S, Remvikos Y, Martin PM, Magdelenat H 1989 Prognostic value of epidermal growth factor receptor in node-positive breast cancer. Breast Cancer Res Treat 14:77
39. Foekens JA, Portengen H, Janssen M, Klijn JGM 1989 Insulinlike growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer. Cancer 63:2139
40. Foekens JA, Portengen H, van Putten WLJ, Trapman AMAC, Reubi J-C, Alexieva-Figusch J, Klijn JGM 1989 Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res 49:7002
41. Fekete M, Wittliff JL, Schally AV 1989 Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer. J Clin Lab Anal 3:137
42. Toi M, Hamade Y, Nakamura T, Mukaida H, Suehiro S, Wada T, Toge T, Niimoto M, Hattori T 1989 Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion. Int J Cancer 43:220
43. Toi M, Nakamura T, Mukaida H, Wada T, Osaki A, Yamada H, Toge T, Niimoto M, Hattori T 1990 Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer. Cancer 65:1980
44. Bauknegt T, Kohler M, Janz J, Pfleiderer A 1989 The occurrence of epidermal growth factor receptors and the charcterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. J Cancer Res Clin Oncol 115:193
45. Zeillinger R, Kury F, Czerwenka K, Kubista E, Sliutz G, Knogler W, Huber J, Zielinski C, Reiner G, Jakesz R, Staffen A, Reiner A, Wrba F, Spona J 1989 HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene 4:109
46. Costa SD, Kaufmann M, Fabbro D, Tokus M, Feichter G, Klinga K, Bastert G 1989 Epidermal growth factor receptors and flow-cytometry in primary breast cancer: relationship to hormone receptor and lymph node status. Geburtshilfe Frauenheilkd 49:375
47. Barker S, Panahy C, Puddefoot JR, Goode AW, Vinson GP 1989 Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast. Br J Cancer 60:673
48. Llorens MA, Bermejo MJ, Salcedo MC, Charro AL, Puente M 1989 Epidermal growth factor receptors in human breast and endometrial carcinomas. J Steroid Biochem 34:505
49. Bolla M, Chedin M, Souvignet C, Marron J, Arnould C, Chambaz E 1990 Estimation of epidermal growth factor receptor in 177 breast cancers: correlation with prognostic factors. Breast Cancer Res Treat 16:97
50. Etienne MC, Formento JL, Francoual M, Formento P, Fischel JL, Namer M, Frenay M, Milano G 1990 Epidermal growth factor receptor assay: validation of a single point saturation method in breast cancer. Eur J Cancer 26:181 (Abstract 139)
51. Lefebvre MF, Garin E, Falette N, Saez S 1990 Evaluation of epidermal growth factor receptor occupancy by EGF-like peptide in 55 breast and 42 non-breast tumor biopsies. Eur J Cancer 26:182 (Abstract 145)
52. Koenders PG, Beex LVAM, Geurts-Moespot A, Heuvel JJTM, Kienhuis CBM, Benraad TJ 1991 Epidermal growth factor receptor negative tumors are predominantly confined to the subgroup of estradiol receptor positive human primary breast cancer. Cancer Res 51:4544
53. Bolufer P, Miralles F, Rodriguez A, Vasquez C, Lluch A, Garcia-Conde J, Olmos T 1990 Epidermal growth factor receptor in human breast cancer: correlation with cytosolic and nuclear ER receptors and with biological and histological tumor characteristics. Eur J Cancer 26:283
54. Spitzer E, Grosse R, Kunde D, Schmidt HE 1987 Growth of mammary epithelial cells in breast-cancer biopsies correlates with EGF binding. Int J Cancer 39:279
55. Spitzer E, Koepke K, Kunde D, Grosse R 1988 EGF binding is quantitatively related to growth in node-positive breast cancer. Breast Cancer Res Treat 12:45
56. Reubi JC, Torhorst J 1988 EGF receptors in human breast cancer on viable and necrotic tumour cells. Breast Cancer Res Treat 12:245
57. Reubi JC, Torhorst J 1989 The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer. Cancer 64:1254
58. Reubi JC, Waser B, Foekens JA, Klijn JGM, Lamberts SWJ, Laissue J 1990 Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors. Int J Cancer 46:416
59. Walker RA, Camplejohn RS 1986 DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol 150:37
60. Wrba F, Reiner A, Ritzinger E, Holzner JH 1988 Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria: an immunohistochemical study. Pathol Res Pract 183:25
61. Betta PG, Robutti F, Spinoglio G, Bottero G 1989 Expression of epidermal growth factor receptor in human breast carcinoma and its correlation with morphological and biological features of tumours aggressiveness. Pathologica 81:425
62. Moller P, Mechtersheimer G, Kaufmann M, Moldenhauer G, Momburg F, Mattfeldt T 1989 Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast. Virchows Arch [Pathol Anat] 414:157
63. Grimaux M, Mady E, Remvikos Y, Laine-Bidron C, Magdelenat H 1990 A simplified immuno-enzymetric assay of the epidermal growth factor receptor in breast tumors: evaluation in 282 cases. Int J Cancer 45:255
64. Gasparini G, Santini G, Reitano M, Meli S, Bevilacqua P 1990 Relationship of the epidermal growth factor receptor (EGFR) with the growth fraction and the flowcytometric S-phase as cell kinetics parameters in human mammary carcinomas. Eur J Cancer 26:182 (Abstract 144)
65. Bevilacqua P, Gasparini G, Dal Fior S, Corradi G 1990 Immuno-cytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients. Oncology 47:313
66. Lewis S, Locker A, Todd JH, Bell JA, Nicholson R, Elston CW, Blarney RW, Ellis IO 1990 Expression of epidermal growth factor receptor in breast carcinoma. J Clin Pathol 43:385
67. Tsutsumi Y, Naber SP, DeLellis RA, Wolfe HJ, Marks PJ, McKenzie SJ, Yin S 1990 Neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. Hum Pathol 21:750
68. Kommoss F, Colley M, Hart CE, Franklin WA 1990 In situ distribution of oncogene products and growth factor receptors in breast carcinoma:c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit. Mol Cell Probes 4:11
69. Hainsworth PJ, Henderson MA, Stillwell RG, Bennett RC 1991 Comparison of EGF-R, C-erbB-2 product and ras p21 immuno-histochemistry as prognostic markers in primary breast cancer. Eur J Surg Oncol 17:9
70. Guerin M, Gabillot M, Mathieu M-C, Travagli J-P, Spielmann M, Andrieu N, Riou G 1989 Structure and expression of c-erb B-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer 43:201
71. Barrett-Lee P, Travers M, Luqmani Y, Coombes RC 1990 Transcripts for transforming growth factors in human breast cancer: clinical correlates. Br J Cancer 61:612
72. Coombes RC, Murray P, Luqmani Y 1990 The prognostic significance of transcripts for transforming growth factor alpha and beta and epidermal growth factor receptor in primary breast cancer. Eur J Cancer 26:159 (Abstract 49)
73. Coombes RC, Barrett-Lee P, Luqmani Y 1990 Growth factor expression in breast tissue. J Steroid Biochem Mol Biol 37:833
74. Baugnet-Mahieu L, Lemaire M 1990 Expression of epidermal growth factor receptor and C-erb B-2 oncoprotein in human tumors. Eur J Cancer 26:181 (Abstract 138)
75. Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M 1988 Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res 48:161
76. Lacroix H, Iglehart JD, Skinner MA, Kraus MH 1989 Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene 4:145
77. Horne GM, Angus B, Wright C, Needham G, Nicholson S, Harris AL, Innes B, Horne HW 1988 Relationships between oestrogen receptor, epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer. J Pathol 155:143
78. Dixon JM, Page DL, Anderson TJ, Lee D, Elton RA, Stewart HJ, Forrest APM 1985 Long-term survivors after breast cancer. Br J Surg 72:445
79. Der Simonian R, Laird N 1986 Meta-analysis in clinical trials. Controlled Clinical Trials 7:177
80. Marx D, Schauer A, Reiche C, May A, Ummenhofer L, Reles A, Rauschecker H, Sauer R, Schumacher M 1990 C-erbB-2 expression in correlation to other biological parameters of breast cancer. J Cancer Res Clin Oncol 116:15
81. Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW 1990 Her-2/neu oncogene expression and proliferation in breast cancers. Am J Pathol 137:103
82. Wright C, Angus B, Nicholson S, Sainsbury JRC, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CHW 1989 Expression of C-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 49:2087
83. Kokai Y, Myers JN, Wada T, Brown VI, LeVea CM, Davis JG, Dobashi K, Green MI 1989 Synergistic interaction of pl85c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58:287
84. Gullick WJ 1990 New developments in the molecular biology of breast cancer. Eur J Cancer 26:509
85. McGuire WL 1989 Adjuvant treatment of node-negative breast cancer. N Engl J Med 320:525
86. Hillner BE, Smith TJ 1991 Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model. N Engl J Med 324:160
87. Klijn JGM, Foekens JA 1990 Prognostic factors in breast cancer. In: Goldhirsch A (ed) Endocrine Therapy of Breast Cancer IV. Monographs European School of Oncology. Springer-Verlag, Berlin, p 17
88. Alexieva-Figusch J, van Putten WLJ, Blankenstein MA, Blonkvan der Wijst Klijn JGM, 1988 The prognostic value and relationships of patient characteristics, progestin receptor, estrogen receptor, and site of relapse in primary and metastatic human breast cancer. Cancer 61:758
89. Kudlow JE, Cheung C-YM, Bjorge JD 1986 Epidermal growth factor stimulates the synthesis of its own receptor in a human breast cancer cell line. J Biol Chem 261:4134
90. Fernandez-Pol JA, Klos DJ, Hamilton PD 1989 Modulation of transforming growth factor alpha-dependent expression of epidermal growth factor receptor gene by transforming growth factor beta, triiodothyronine, and retinoic acid. J Cell Biochem 41:159
91. Macias A, Perez R, Hägerström T, Skoog L 1989 Transforming growth factor alpha in human mammary carcinomas and their metastases. Anticancer Res 9:177
92. Dotzlaw H, Miller T, Karvelas J, Murphy LC 1990 Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res 50:4204
93. Benraad TJ, Foekens JA 1990 Hydroxyapatite assay to measure epidermal growth factor receptor in human primary breast tumours. Ann Clin Biochem 27:272
94. MaGuire HC, Greene MI 1989 The neu (c-erbB-2) oncogene. Semin Oncol 16:148
95. Gullick WJ 1990 The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer. Int J Cancer [Suppl] 5:55
96. Clark GM, McGuire WL 1991 Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res 51:944
97. Perren TJ 1991 C-erbB-2 oncogene as a prognostic marker in breast cancer. Br J Cancer 63:328
98. Berns PMJJ, Klijn JGM, Foeken JA 1992 Oncogene amplification in human breast and ovarian cancer. In: Spandidos DA (ed) Current Perspectives on Molecular and Cellular Oncology. JAI Press Ltd, London, in press
99. Berns PMJJ, Klijn JGM, van Staveren IL, Foekens JA 1992 HER-2/neu gene amplification in primary human breast cancer. In: Jonat W, Lönnig T (eds) Proceedings International Symposium on the Clinical and Scientific Relevance of HER-2/neu/erbB2. Springer Verlag, Berlin, in press
100. Klijn JGM, Berns PMJJ, Bontenbal M, Alexieva-Figusch J, Foekens JA 1992 Clinical breast cancer, new developments in selection and endocrine treatment of patients. J Steroid Biochem Mol Biol, in press
101. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogerie. Science 235:177
102. Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS, McCarty Jr KS 1989 Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res 49:1052